Abstract: The morbidity of lymphomas increased yearly. As a whole-body functional metabolic imaging modality, ¹⁸F-FDG PET was very valuable in the diagnosing, staging, selecting treatment program, evaluating therapeutic response and differentiating residual mass. PET had been recognized as a helpful modality because it can provide much more additional information than conventional imaging. However, there was some false positive and false negative.